June 2013: Request for Renewal of MEDS-AD 1115 Research and Demonstration Waiver
The Agency for Health Care Administration (Agency) is seeking to renew federal waiver authority to continue providing Medicaid eligibility to the MEDS-AD group, according to provisions of Section 409.904(1), Florida Statutes, which states:
Subject to federal waiver approval, a person who is age 65 or older or is determined to be disabled, whose income is at or below 88 percent of the federal poverty level, whose assets do not exceed established limitations, and who is not eligible for Medicare or, if eligible for Medicare, is also eligible for and receiving Medicaid-covered institutional care services, hospice services, or home and community-based services. The agency shall seek federal authorization through a waiver to provide this coverage.
Since January 2006, Medicaid eligibility for this group has been authorized through the Florida Medicaid MEDS-AD 1115 Research and Demonstration Waiver #11-W-00205/4. The current federal approval for this waiver will expire on December 31, 2013. Florida Medicaid is requesting a renewal of authority to continue the program as it currently operates through December 31, 2016.
Renewal Request Submitted
On June 28, 2013, the Agency submitted a 3-year waiver renewal request to the Centers for Medicare and Medicaid Services. The waiver renewal request can be viewed by clicking on the link below. If you have comments, please submit them to the Agency via mail or email (see below).
MEDS-AD Waiver Renewal Request
Public Input
The Agency must allow a 30-day public notice and comment period regarding renewal applications for a demonstration project that the Agency plans to submit to federal CMS for review and consideration. The Agency will consider the public comments while developing the renewal application for the MEDS-AD 1115 Research and Demonstration waiver. To view a comprehensive description for the renewal of the MEDS-AD 1115 Research and Demonstration waiver, please click the link to the public notice document .
Public Workshops
Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 7 days before the workshop/meeting by contacting Marie Donnelly at (850) 412-4166 or by email at [email protected]. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1 (800) 955-8771 (TDD) or 1 (800) 955-8770 (Voice).
------------------------------------------
Wednesday, May 15, 2013
Location:
Medicaid Area Office 6
6800 N. Dale Mabry Hwy
Suite 220 Tampa FL 33614
(813) 350-4800
1-800-226-2316
Time: 2:00 pm, Eastern Daylight Time (New York, GMT-04:00)
------------------------------------------
Tuesday, May 28, 2013
Location: Webinar Only
Time: 1:00 pm, Eastern Daylight Time (New York, GMT-04:00)
Submit Comments
To comment by postal service or internet, please follow directions outlined in the “Comments or Questions” informational box located on the top right hand side of page. When providing comments regarding the MEDS-AD program, please have ‘MEDS-AD’ referenced in the subject line.
- For more information on 1115 Research and Demonstration waivers you may visit the Federal CMS website at the following link https://www.medicaid.gov/medicaid/section-1115-demonstrations/index.html.
- The Agency will post all public comments here periodically throughout the 30-day public notice and comment period.
- The MEDS-AD 1115 waiver renewal application 30-day public comment period began May 1, 2013. Public comment was received via the public meetings held in Tampa 5/15 and Tallahassee 5/28. Public comment will continue to be received via the [email protected] email, and U.S. Postal service mail to 2727 Mahan Drive, Tallahassee, FL 32308. Public comments will be posted as they become available.
Please mail your comments or suggestions to:
MEDS-AD Renewal
Office of the Deputy Secretary for Medicaid
Agency for Health Care Administration
2727 Mahan Drive, MS #8
Tallahassee, Florida 32308
Email your comments and suggestions on MEDS-AD to
[email protected]